Taxifolin

Compound Taxifolin 
Animal species human intestinal bacteria Eubacterium sp. strain SDG-2 
Metabolism parameters  
Metabolites (+)-(2R, 3R)-Taxifolin
(R)-3-(3,4-dihydroxyphenyl)-2-hydroxy-1-(2,4,6-trihydroxyphenyl)propan-1-one
Crude drug Oriental Arborvitae Leafy Twig 
References 1) Wang L., Meselhy M. R., Li Y., Nakamura N., Min B., Qin G. and Hattori M.: The heterocyclic ring fission and dehydroxylation of catechins and related compounds by Eubacterium sp. strain SDG-2, a human intestinal bacterium. Chem. Pharm. Bull., 49, 1640-1643 (2001). 
Remarks ・Incubation of (+)-taxifolin with Eubacterium sp. strain SDG-2
(+)-Taxifolin (25 mg in 1 ml MeOH) was anaerobically incubated with a bacterial suspension (50 ml) for 3 d. The reaction mixture was then treated as usual to give compound 2 (12 mg). [Wang et al., Chem. Pharm. Bull., 49, 1640-1643 (2001)]
 
 

TOPICS

Information on genetic analysis

Information of bioassay

Metabolism information on chemical compounds included in crude drugs

Traditional Medical & Pharmaceutical Database


Section of Pharmacognosy,
Division of Medicinal Resources,
Department of Research and Development,
Institute of Natural Medicine,
University of Toyama
2630 Sugitani, Toyama 930-0194 Japan
TEL: +81-76-434-7601
FAX: +81-76-434-5064